|
Market Closed -
NYSE
16:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 26.11 USD | +0.81% |
|
-9.97% | -15.77% |
| 08-14 | Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating | MT |
| 08-13 | Pelthos Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.81% | -9.97% | -3.26% | -2.28% | -15.77% | +24.57% | - | - | - | 90.02M | |
| +3.60% | -0.50% | +3.95% | +21.97% | +14.06% | +74.80% | +127.97% | +349.46% | +1,430.06% | 1,055B | |
| +3.33% | +3.55% | +7.14% | +19.58% | +31.00% | +53.48% | +55.80% | +51.06% | +123.49% | 632B | |
| +3.43% | +4.42% | +1.74% | +23.07% | +13.32% | +25.27% | +72.59% | +116.38% | +287.43% | 442B | |
| +1.35% | -3.27% | +7.99% | +11.80% | +9.96% | +40.98% | +39.91% | -2.46% | +47.91% | 351B | |
| +1.75% | -0.98% | +0.45% | +7.61% | +14.56% | +26.20% | +39.73% | +44.75% | +59.85% | 290B | |
| +2.13% | -1.53% | -6.26% | -13.39% | -14.39% | +1.85% | +9.40% | +37.52% | +132.91% | 243B | |
| +1.41% | +1.94% | +16.10% | +30.33% | +29.93% | +43.45% | +61.18% | +83.94% | +143.98% | 227B | |
| +1.35% | -3.20% | -10.17% | -0.95% | -8.89% | -9.07% | -53.51% | -10.47% | +91.63% | 200B | |
| +3.25% | +7.80% | +6.82% | +10.70% | +16.86% | +21.18% | +87.50% | +96.41% | +77.74% | 172B | |
| +1.41% | +0.74% | +8.78% | +7.58% | +9.44% | +8.39% | -25.36% | -45.95% | -22.45% | 153B | |
| +2.20% | +1.87% | +8.74% | +15.88% | +22.45% | +36.35% | +6.28% | -4.22% | +13.29% | 132B | |
| +2.45% | +0.82% | +8.76% | +20.88% | +16.51% | +34.47% | +53.60% | +166.17% | +428.77% | 131B | |
| +1.32% | +2.83% | +0.43% | +5.02% | -6.10% | -8.57% | -20.48% | -13.01% | +10.88% | 106B | |
| +1.97% | -2.05% | -1.49% | +1.37% | +3.48% | +32.49% | +39.05% | -0.40% | -10.12% | 101B | |
| -0.25% | -3.73% | -6.53% | -13.74% | -16.94% | +9.67% | +60.31% | +68.27% | +491.11% | 70.87B | |
| +3.43% | +2.15% | +4.05% | +8.05% | +17.93% | +29.33% | +28.45% | +56.18% | +21.58% | 55.24B | |
| +1.75% | -1.00% | +0.58% | +29.25% | +31.69% | +80.22% | -5.05% | +1.84% | -49.04% | 54.51B | |
| -0.95% | -3.34% | -1.54% | -3.00% | -12.09% | -17.40% | +29.09% | -4.35% | +214.56% | 51.66B | |
| +0.33% | +1.22% | +14.21% | +6.68% | +17.21% | +104.82% | +284.65% | +285.86% | -31.09% | 42.49B | |
| Average | +1.20% | -1.91% | +3.03% | +9.32% | +8.71% | +30.62% | +46.90% | +67.21% | +182.24% | 225.51B | |
| Weighted average by Cap. | +0.81% | -1.74% | +3.88% | +14.46% | +13.38% | +40.17% | +60.59% | +119.67% | +430.55% |
- Stock Market
- Stocks
- PTHS Stock
- Sector Pelthos Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
